tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Janux Therapeutics 5.32M share Secondary priced at $63.00

The deal size was increased to $350M from $300M and priced below last closing price of $66.83. BofA, TD Cowen, Stifel, Cantor Fitzgerald and William Blair are acting as joint book running managers for the offering.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1